Wenhui Hu

1.3k total citations
50 papers, 1.0k citations indexed

About

Wenhui Hu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Wenhui Hu has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Wenhui Hu's work include Inflammasome and immune disorders (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Alzheimer's disease research and treatments (8 papers). Wenhui Hu is often cited by papers focused on Inflammasome and immune disorders (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Alzheimer's disease research and treatments (8 papers). Wenhui Hu collaborates with scholars based in China, United States and Hong Kong. Wenhui Hu's co-authors include D. Martin Watterson, Linda J. Van Eldik, Hantamalala Ralay Ranaivo, Jeffrey M. Craft, Ping Sun, Zhongjin Yang, Yitao Ou, Lenka Munoz, Saktimayee M. Roy and Yue Hu and has published in prestigious journals such as Brain Research, Free Radical Biology and Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Wenhui Hu

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenhui Hu China	18	495	209	198	171	167	50	1.0k
Sowmya Chollate United States	6	650 1.3×	248 1.2×	107 0.5×	84 0.5×	269 1.6×	6	1.3k
Nathan T. Ross United States	13	514 1.0×	206 1.0×	259 1.3×	236 1.4×	79 0.5×	26	1.1k
Jiahong Sun China	23	658 1.3×	214 1.0×	171 0.9×	51 0.3×	123 0.7×	55	1.4k
Piao Luo China	21	654 1.3×	186 0.9×	91 0.5×	37 0.2×	178 1.1×	54	1.4k
Mónika Vastag Hungary	18	311 0.6×	296 1.4×	67 0.3×	140 0.8×	44 0.3×	42	1.1k
Natalia Mast United States	28	1.2k 2.4×	78 0.4×	219 1.1×	53 0.3×	116 0.7×	70	2.3k
О.А. Бунеева Russia	18	610 1.2×	44 0.2×	108 0.5×	128 0.7×	47 0.3×	90	1.0k
Marina Villanueva‐Paz Spain	18	703 1.4×	85 0.4×	206 1.0×	58 0.3×	63 0.4×	34	1.2k
Mark J. Bamford United Kingdom	20	694 1.4×	109 0.5×	56 0.3×	524 3.1×	70 0.4×	41	1.2k

Countries citing papers authored by Wenhui Hu

Since Specialization

Citations

This map shows the geographic impact of Wenhui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhui Hu more than expected).

Fields of papers citing papers by Wenhui Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhui Hu. The network helps show where Wenhui Hu may publish in the future.

Co-authorship network of co-authors of Wenhui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhui Hu. A scholar is included among the top collaborators of Wenhui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhui Hu. Wenhui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ruiwen, Xiuxiu Zhang, Yiming Luo, et al.. (2025). Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors. European Journal of Medicinal Chemistry. 289. 117466–117466. 1 indexed citations

Zhang, Xiuxiu, Ruiwen Wu, Yiming Luo, et al.. (2025). Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease. European Journal of Medicinal Chemistry. 298. 118023–118023. 1 indexed citations

Li, Xianjing, Yiya Wang, Wenhui Hu, Qinxin Song, & Li Ding. (2024). Development and validation of pharmacokinetics assays for a novel HER2-targeting antibody-drug conjugate (SHR-A1201): Application to its dose-escalation pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 240. 115964–115964. 7 indexed citations

Ou, Yitao, Zhongjin Yang, Yue Hu, et al.. (2024). Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation. European Journal of Pharmacology. 965. 176331–176331. 4 indexed citations

Wang, Xianwei, Lu Liu, Xiaohua Jiang, et al.. (2023). Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease. Alzheimer s Research & Therapy. 15(1). 164–164. 4 indexed citations

Yang, Cheng, Wenhui Hu, Xingxing Diao, et al.. (2023). Pharmacokinetics, Mass Balance, Tissue Distribution and Metabolism of[14C]101BHG-D01, a Novel Muscarinic Receptor Antagonist, in Rats. Current Drug Metabolism. 24(11). 770–779. 2 indexed citations

Zhang, Jing, Wenwen Zhou, Yunyu Chen, et al.. (2023). Small molecules targeting Pin1 as potent anticancer drugs. Frontiers in Pharmacology. 14. 1073037–1073037. 17 indexed citations

Yang, Zhongjin, Yitao Ou, Lin Geng, et al.. (2023). Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation. Cellular and Molecular Life Sciences. 80(8). 230–230. 10 indexed citations

Chen, Yanhong, Shuli Liang, Yitao Ou, et al.. (2022). Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Chemico-Biological Interactions. 365. 110122–110122. 10 indexed citations

10.

Huang, Zhihua, et al.. (2022). AD-16 Protects Against Hypoxic-Ischemic Brain Injury by Inhibiting Neuroinflammation. Neuroscience Bulletin. 38(8). 857–870. 9 indexed citations

11.

Sun, Luning, Wenhui Hu, Yiya Wang, et al.. (2020). Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects. Frontiers in Pharmacology. 11. 1033–1033. 3 indexed citations

12.

Zeng, Shaogao, Manna Li, Yang Zhou, et al.. (2020). Discovery of an Orally Active and Long‐Acting DPP‐IV Inhibitor through Property‐Based Optimization with an in Silico Biotransformation Prediction Tool. ChemMedChem. 15(16). 1608–1617. 1 indexed citations

13.

Zhao, Xin, Runfeng Li, Yang Zhou, et al.. (2018). Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of Medicinal Chemistry. 61(12). 5187–5198. 27 indexed citations

14.

Zeng, Shaogao, Yuwen He, Guicheng Zhang, et al.. (2017). Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluation. European Journal of Medicinal Chemistry. 141. 519–529. 14 indexed citations

15.

Zeng, Lili, Shaogao Zeng, Xin Lü, et al.. (2013). Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization. European Journal of Medicinal Chemistry. 68. 312–320. 18 indexed citations

16.

Zhou, Wei, Shaogao Zeng, Tianyan Chi, et al.. (2012). Identification of Aminopyridazine-Derived Antineuroinflammatory Agents Effective in an Alzheimer's Mouse Model. ACS Medicinal Chemistry Letters. 3(11). 903–907. 16 indexed citations

17.

Peng, Li, Guicheng Zhang, Xiaobing Lan, et al.. (2010). The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes. European Journal of Medicinal Chemistry. 46(1). 71–76. 43 indexed citations

18.

Munoz, Lenka, Hantamalala Ralay Ranaivo, Saktimayee M. Roy, et al.. (2007). A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Journal of Neuroinflammation. 4(1). 21–21. 197 indexed citations

19.

Hu, Wenhui, Hantamalala Ralay Ranaivo, Saktimayee M. Roy, et al.. (2006). Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits. Bioorganic & Medicinal Chemistry Letters. 17(2). 414–418. 56 indexed citations

20.

Craft, Jeffrey M., et al.. (2004). Aminopyridazines Attenuate Hippocampus-Dependent Behavioral Deficits Induced by Human β-Amyloid in a Murine Model of Neuroinflammation. Journal of Molecular Neuroscience. 24(1). 115–122. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact